| Literature DB >> 24619303 |
Yunyang Lu1, Kai Gao2, Xiaoyang Wang3, Wei Zhang4, Ning Ma5, Haifeng Tang6.
Abstract
Five new alkaloids,Entities:
Mesh:
Substances:
Year: 2014 PMID: 24619303 PMCID: PMC6271962 DOI: 10.3390/molecules19033055
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Structures of compounds 1–9.
1H-NMR (500 MHz) and 13C-NMR (125 MHz) data for compounds 1–5 (δ in ppm, J in Hz).
| C | 1 a | 2 a | 3 a | 4 a | 5 b | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| δC | δH | δC | δH | δC | δH | δC | δH | δC | δH | |
| 1 | 77.8 | - | 78.9 | - | 209.2 | - | 217.6 | - | 216.4 | - |
| 2 | 213.1 | - | 212.4 | - | 44.4 | 2.93 (t, 3.1) | 43.3 | 2.38 (brd, 5.0) | 41.5 | 2.28–2.31 (m) |
| 3a | 31.4 | 2.26 (d, 3.4) | 33.9 | 2.18 (d, 14.8) | 24.4 | 1.97 (dt, 14.1, 2.7) | 34.6 | 1.86–1.92 (m) | 18.6 | 2.38–2.40 (m) |
| 4 | 67.9 | 3.50 (t, 3.3) | 98.0 | - | 64.6 | 3.07–3.09 (m) | 90.4 | 4.00 (t, 2.2) | 87.9 | 3.93 (br s) |
| 5 | 46.8 | - | 53.3 | - | 55.9 | - | 54.7 | - | 52.5 | - |
| 6 | 46.7 | 2.56–2.58 (m) | 42.3 | 2.85–2.88 (m) | 58.0 | 1.78–1.85 (m) | 47.2 | 3.01–3.07 c | 45.2 | 2.89 (t, 7.6) |
| 7a | 60.1 | 2.37 (t, 9.6) | 59.4 | 2.31 (dd, 8.2, 2.8) | 61.9 | 2.92 (d, 9.4) | 69.6 | 3.12 (t, 6.3) | 67.4 | 3.04–3.09 (m) |
| 8 | 126.7 | - | 128.5 | - | 57.3 | - | 72.3 | - | 69.7 | - |
| 9 | 108.8 | - | 108.2 | - | 150.7 | - | 139.7 | - | 136.9 | - |
| 10 | 168.4 | - | 168.1 | - | 151.7 | - | 206.1 | - | 202.8 | - |
| 11a | 31.0 | 2.98–3.01 (m) | 31.1 | 2.94–2.98 (m) | 34.5 | 2.06–2.14 (m) | 37.2 | 2.32–2.35 (m) | 36.0 | 2.12–2.15 (m) |
| 12a | 28.2 | 1.69–1.73 (m) | 27.6 | 1.67–1.75 (m) | 32.1 | 1.32–1.37 (m) | 19.4 | 1.86–1.92 (m) | 17.8 | 1.71–1.74 (m) |
| 13a | 142.0 | - | 141.5 | - | 47.6 | 2.81 (d, 16.5) | 20.2 | 2.44–2.50 (m) | 32.9 | 1.68–1.71 (m) |
| 14a | 123.2 | - | 123.3 | - | 115.9 | - | 33.2 | 2.64 (t, 8.7) | 35.9 | 2.32–2.37 (m) |
| 15 | 134.4 | - | 134.7 | - | 173.5 | - | 154.6 | - | 156.4 | - |
| 16a | 111.8 | 7.70 (d, 5.3) | 117.7 | 7.69 (d, 5.3) | 26.8 | 2.74–2.78 (m) | 132.5 | 6.89 (dd, 10.8, 6.7) | 33.3 | 2.18–2.23 (m) |
| 17a | 146.1 | 7.93 (d, 5.3) | 145.9 | 7.92 (d, 5.3) | 41.7 | 2.78–2.80 (m) | 122.2 | 5.42 (d, 10.8) | 59.1 | 3.43–3.45 (m) |
| 18 | 36.9 | 2.66–2.70 (m) | 39.1 | 2.49–2.53(m) | 112.8 | - | 33.0 | 2.57–2.62(m) | 31.0 | 2.43–2.47 (m) |
| 19a | 53.1 | 2.61–2.65 (m) | 53.8 | 2.91 (dd, 15.6, 2.8) | 135.8 | 5.77(s) | 68.2 | 3.01–3.07 c | 66.1 | 2.99–3.04 (m) |
| 20 | 14.0 | 0.81 (3H, d, 6.7) | 13.3 | 0.83 (3H, d, 6.7) | 19.9 | 1.70 (3H, s) | 19.6 | 1.14 (3H, d, 6.7) | 18.9 | 1.03 (3H, d, 6.7) |
| 21 | 28.8 | 1.48 (3H, s) | 25.6 | 1.46 (3H, s) | 27.2 | 1.20 (3H, s) | 23.2 | 1.50 (3H, s) | 22.1 | 1.39 (3H, s) |
| 22 | 169.0 | - | 169.0 | - | 168.1 | - | - | - | - | - |
| 23 | 51.9 | 3.83 (3H, s) | 51.8 | 3.82 (3H, s) | 51.8 | 3.70 (3H, s) | - | - | - | - |
| 4-OMe | - | - | 50.0 | 3.35 (3H, s) | - | - | - | - | - | - |
a Measured in CD3OD; b Measured in DMSO-d; c Overlapped.
Figure 2Selected 2D NMR correlations of daphnicyclidin M (1).
Figure 3Key NOESY correlations of daphnicyclidin M (1).
Figure 4Selected 2D NMR correlations of calyciphylline Q (3).
Figure 5Key NOESY correlations of calyciphylline Q (3).
Cytotoxic activity of compounds 1–9 against four cancer cell lines in vitro.
| Compounds a | Cytotoxic activity (IC50, µM) | |||
|---|---|---|---|---|
| P-388 | A-549 | SGC-7901 | HL-60 | |
| 5.7 | >50 | 22.4 | >50 | |
| 6.5 | >50 | 25.6 | >50 | |
| 10.3 | >50 | >50 | >50 | |
| 13.8 | >50 | >50 | >50 | |
| Cisplatin b | 0.3 | 0.9 | 3.2 | 1.1 |
P-388 = mouse lymphocytic leukemia cell line; A-549 = human lung carcinoma cell line; SGC-7901 = human gastric carcinoma cell line; HL-60 = human promyelocytic leukemia cell line; a Compounds 3, 4, 5, 6 and 7 were inactive (IC50 > 50 µM) against all cell lines; b Cisplatin was used as positive control.